Redwood Scientific Technologies, Inc. (RSCI)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
Sep 9, 2025, 8:00 PM EDT
RSCI Market Cap
RSCI has a market cap or net worth of $14.35 million as of September 11, 2025. Its market cap has increased by 167.87% in one year.
Market Cap
14.35M
Enterprise Value
n/a
Revenue
259.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since October 22, 2009, RSCI's market cap has decreased from 1.71B to 14.35M, a decrease of -99.16%. That is a compound annual growth rate of -26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 14.35M | -32.43% |
| Dec 31, 2024 | 21.23M | -6.40% |
| Dec 27, 2023 | 22.68M | 2,024.85% |
| Dec 30, 2022 | 1.07M | -87.98% |
| Dec 29, 2020 | 8.88M | 399.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 780.18M |
| Elite Pharmaceuticals | 742.62M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 345.48M |